XML 34 R24.htm IDEA: XBRL DOCUMENT
v3.25.1

Note 15 - Segment and Geographic Information | 6 Months Ended
--- | ---
Mar. 31, 2025
Notes to Financial Statements |
Segment Reporting Disclosure [Text Block] | 15. Segment and Geographic Information Operating segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker (“CODM”) in deciding how to allocate resources and to assess performance. The Company’s Chief Executive Officer is the Company’s CODM. As of November 12, 2024, the Company’s B Medical Systems segment met the “held for sale” criteria and “discontinued operations” criteria in accordance with FASB ASC 205 and the results of the B Medical Systems segment are included within discontinued operations. The Company’s continuing operations includes the following operating and reportable segments: ​
| ● | Sample Management Solutions. The SMS business resources operate as a single business unit offering end-to-end sample management products and services, including: Sample Repository Services and Core Products (Automated Stores, Cryogenic Systems, Automated Sample Tube, Consumables and Instruments and Controlled Rate Thawing Devices).
| ● | Multiomics. The Multiomics business resources operate as a single business unit offering genomic and other sample analysis services, including gene sequencing and gene synthesis.
Management considers adjusted operating income (loss), which excludes charges related to amortization of intangible assets, transformation costs, restructuring charges, goodwill and intangible asset impairment, merger and acquisition costs and costs related to share repurchase, governance-related matters, and other unallocated corporate expenses, as the primary performance metric when evaluating each segment’s operations. The following is the summary of the financial information for the Company’s operating and reportable segments for the three and six months ended March 31, 2025 and 2024 (in thousands):
​ |  | Three Months Ended March 31, |  |  | Six Months Ended March 31, |
​ |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Revenue: |  | ​ |  |  |  |  |  |  |  |  |  |  |  |  |
Sample Management Solutions |  | $ | 79,896 |  |  | $ | 74,137 |  |  | $ | 161,108 |  |  | $ | 153,142 |
Multiomics |  |  | 63,522 |  |  |  | 62,218 |  |  |  | 129,820 |  |  |  | 124,938 |
Total revenue |  | $ | 143,418 |  |  | $ | 136,355 |  |  | $ | 290,928 |  |  | $ | 278,080 |
​ |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Adjusted operating income (loss): |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Sample Management Solutions |  | $ | 4,613 |  |  | $ | (1,457 | ) |  | $ | 6,930 |  |  | $ | (2,073 | )
Multiomics |  |  | (5,296 | ) |  |  | (2,880 | ) |  |  | (7,796 | ) |  |  | (6,144 | )
Segment adjusted operating loss |  |  | (683 | ) |  |  | (4,337 | ) |  |  | (866 | ) |  |  | (8,217 | )
​ |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Amortization of completed technology |  |  | 2,308 |  |  |  | 2,067 |  |  |  | 3,808 |  |  |  | 3,923 |
Amortization of other intangible assets |  |  | 3,803 |  |  |  | 5,152 |  |  |  | 8,376 |  |  |  | 10,523 |
Transformation costs (1) |  |  | 5,183 |  |  |  | 4,095 |  |  |  | 8,229 |  |  |  | 4,136 |
Restructuring charges |  |  | 3,580 |  |  |  | 3,428 |  |  |  | 4,011 |  |  |  | 4,214 |
Impairment of intangible assets |  |  | — |  |  |  | 4,658 |  |  |  | — |  |  |  | 4,658 |
Merger and acquisition costs and costs related to share repurchase (2) |  |  | 688 |  |  |  | 426 |  |  |  | 2,258 |  |  |  | 4,747 |
Other unallocated corporate expenses |  |  | (94 | ) |  |  | 50 |  |  |  | (44 | ) |  |  | 40 |
Total operating loss |  |  | (16,151 | ) |  |  | (24,213 | ) |  |  | (27,504 | ) |  |  | (40,458 | )
Interest income, net |  |  | 4,489 |  |  |  | 9,479 |  |  |  | 8,787 |  |  |  | 19,434 |
Other income (expense), net |  |  | 1,157 |  |  |  | (268 | ) |  |  | 2,360 |  |  |  | 250 |
Loss before income taxes |  | $ | (10,505 | ) |  | $ | (15,002 | ) |  | $ | (16,357 | ) |  | $ | (20,774 | )
(1) | Transformation costs represent non-recurring expenses for strategic projects with anticipated long-term benefits to the Company focused on cost reduction and productivity improvement that do not meet the definition of restructuring charges. These costs are directed at simplifying, standardizing, streamlining, and optimizing the Company’s operations, processes and systems to permanently alter the Company’s operations for the long term. For a project to be considered transformational, successful completion of the project must be expected to bring long-term material benefits to the organization and involve significant changes to process and/or underlying technology. Transformation costs in the period result from actions taken as part of the Company’s 2024 transformation plan and primarily relate to one time asset write downs associated with changes in technology, one time inventory write downs relating to restructuring actions taken in the period, and third-party consulting costs associated with process and systems re-design.
(2) | Includes expenses related to governance-related matters.
​ The following is the summary of the asset information for the Company’s reportable segments as of March 31, 2025 and September 30, 2024 (in thousands):
Assets: |  | March 31, 2025 |  |  | September 30, 2024 |
Sample Management Solutions |  | $ | 847,215 |  |  | $ | 859,353 |
Multiomics |  |  | 450,641 |  |  |  | 462,825 |
Total assets |  | $ | 1,297,856 |  |  | $ | 1,322,178 |
The following is a reconciliation of the segment assets to the corresponding amounts presented in the Condensed Consolidated Balance Sheets as of March 31, 2025 and September 30, 2024 (in thousands):
​ |  | March 31, |  |  | September 30, |
​ |  | 2025 |  |  | 2024 |
Segment assets |  | $ | 1,297,856 |  |  | $ | 1,322,178 |
Cash and cash equivalents, restricted cash and marketable securities |  |  | 513,319 |  |  |  | 490,707 |
Deferred tax assets |  |  | 731 |  |  |  | 837 |
General corporate assets |  |  | 9,302 |  |  |  | 23,631 |
Assets held for sale |  |  | 220,717 |  |  |  | 262,688 |
Total assets |  | $ | 2,041,925 |  |  | $ | 2,100,041 |
Revenue from external customers is attributed to geographic areas based on locations in which the product is shipped. Net revenue by geographic area for the three and six months ended March 31, 2025 and 2024 are as follows (in thousands):
​ |  | Three Months Ended March 31, |  |  | Six Months Ended March 31, |
​ |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Geographic Location: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
United States |  | $ | 89,943 |  |  | $ | 87,735 |  |  | $ | 183,412 |  |  | $ | 177,861 |
China |  |  | 12,739 |  |  |  | 13,646 |  |  |  | 27,626 |  |  |  | 28,544 |
United Kingdom |  |  | 8,083 |  |  |  | 5,625 |  |  |  | 15,881 |  |  |  | 11,301 |
Rest of Europe |  |  | 25,259 |  |  |  | 22,393 |  |  |  | 49,578 |  |  |  | 45,123 |
Asia Pacific/Other |  |  | 7,394 |  |  |  | 6,956 |  |  |  | 14,431 |  |  |  | 15,251 |
Total revenue |  | $ | 143,418 |  |  | $ | 136,355 |  |  | $ | 290,928 |  |  | $ | 278,080 |
For the three and six months ended March 31, 2025 and 2024, the Company did not have any individual customers that accounted for 10% or more of its consolidated revenue. As of March 31, 2025 and September 30, 2024, there were no customers that accounted for more than 10% of the Company's accounts receivable balance.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration